French animal health company Ceva Sante Animale acquired a pair of Canadian companies, Ceva reported today. Ceva acquired veterinary product manufacturer and distributor CentaurVA Animal Health and poultry vaccine manufacturer Vetech Laboratories, both of Guelph, Ontario. “Canada is an important world economy where we needed to have a direct presence,” said Marc Prikazsky, CEO of Ceva. Ceva previously had a limited presence in Canada, according to Craig Wallace, North America Zone Director for Ceva. The acquisitions establish a foundation for Ceva’s plan to build a broad-based Canadian animal health business, Wallace added. Centaur manufactures and distributes products for small and large animal veterinary practitioners, including nutraceuticals, joint therapies and infection-control products. “[The Centaur acquisition] helps in marketing and distributing current Ceva products and will serve as a strong foundation for future product launches,” Wallace said. Vetech produces live coccidiosis vaccines for poultry under the trade name Immucox. Production of Immucox will remain primarily in Canada, but Ceva will improve the vaccine through the company’s technology and expertise in the field of poultry health, Wallace said. The terms of the deals were not disclosed. <Home>
